Tandem Diabetes Care Stock News

U.S. stocks closed lower, with the Nasdaq dropping 150 points on Tuesday. Here is the list of some big stocks moving lower in the previous session. Magic Empire Global Limited (NASDAQ: MEGL) dipped

Upgrades For Nutrien Ltd (NYSE:NTR), Scotiabank upgraded the previous rating of Sector Perform to Sector Outperform. Nutrien earned $5.85 in the second quarter, compared to $2.08 in the year-ago quar

Heska, Tandem Diabetes Care, Credit Suisse Group, Zalando SE and Las Vegas Sands are part of Zacks Screen of the Week article.

Raymond James cut the price target on NVIDIA Corporation (NASDAQ: NVDA) from $250 to $240. Raymond James analyst Melissa Fairbanks maintained the stock with a Strong Buy. NVIDIA shares fell 2.8% to

Toxic companies are characterized by huge debt pile and are vulnerable to external shocks. Accurately identifying such stocks and getting rid of them at the right time can protect your portfolio. CS,

Toxic companies are characterized by huge debt pile and are vulnerable to external shocks. Accurately identifying such stocks and getting rid of them at the right time can protect your portfolio.

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per sh

AMTD Digital Inc. (NYSE: HKD) dipped 43.6% to $620.00 on possible profit taking after the stock surged over the last few trading days. AMTD IDEA Group (NASDAQ: AMTD) fell 36.2% to $3.9709 after dropp

Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday. Onion Global Limited (NYSE: OG) gained 113.9% to $0.8556. ChemoCentryx,

The diabetes specialist's Q2 financial report isn't sitting well with investors.

Analysts have provided the following ratings for Tandem Diabetes Care (NASDAQ:TNDM) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 0

Factoring the pandemic and competitive pressure as well as the evolving economic environment, including inflation and the threat of recession, Tandem Diabetes (TNDM) cuts its full-year guidance.

The diabetes specialist's Q2 financial report isn't sitting well with investors.

Tandem Diabetes Care, Inc. (NASDAQ:TNDM ) Q2 2022 Earnings Conference Call August 3, 2022 4:30 PM ET Company Participants Susan Morrison - Executive VP & Chief Administrative Officer John Sheridan - P

Investors need to pay close attention to Tandem Diabetes Care (TNDM) stock based on the movements in the options market lately.